Attached files
| file | filename |
|---|---|
| EX-99.2 - EX-99.2 - EXPRESS SCRIPTS INC | c66086exv99w2.htm |
| EX-99.1 - EX-99.1 - EXPRESS SCRIPTS INC | c66086exv99w1.htm |
| EX-99.5 - EX-99.5 - EXPRESS SCRIPTS INC | c66086exv99w5.htm |
| EX-99.3 - EX-99.3 - EXPRESS SCRIPTS INC | c66086exv99w3.htm |
| EX-99.4 - EX-99.4 - EXPRESS SCRIPTS INC | c66086exv99w4.htm |
| EX-99.6 - EX-99.6 - EXPRESS SCRIPTS INC | c66086exv99w6.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 2, 2011
Express Scripts, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 0-20199 | 43-1420563 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| One Express Way, St. Louis, MO | 63121 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code 314-996-0900
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
| þ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events
Beginning September 2, 2011, Express Scripts, Inc. distributed the following materials each of
which is attached hereto and is incorporated herein by reference:
| • | Benefits of Express Scripts — Medco Merger to independent pharmacies (Exhibit 99.1) |
| • | The Express Scripts — Medco Merger: A Partnership Driven by a Competitive Market (Exhibit 99.2) |
| • | The Express Scripts — Medco Merger’s Approach to Better Patient Care (Exhibit 99.3) |
| • | The Express Scripts — Medco Merger: A Partnership for Lower Costs (Exhibit 99.4) |
| • | Express Scripts — Medco: A Partnership for Better Patient Outcomes, Lower Costs (Exhibit 99.5) |
| • | Health Care Reform Bullets (Exhibit 99.6) |
Item 9.01. Financial Statements and Exhibits.
| Exhibit No. | Description | |||
| 99.1 | Benefits of Express Scripts — Medco Merger to independent pharmacies |
|||
| 99.2 | The Express Scripts — Medco Merger: A Partnership Driven by a Competitive Market |
|||
| 99.3 | The Express Scripts — Medco Merger’s Approach to Better Patient Care |
|||
| 99.4 | The Express Scripts — Medco Merger: A Partnership for Lower Costs |
|||
| 99.5 | Express Scripts — Medco: A Partnership for Better Patient Outcomes, Lower Costs |
|||
| 99.6 | Health
Care Reform Bullets |
|||
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| EXPRESS SCRIPTS, INC. (Registrant) |
||||
| By: | /s/ Keith Ebling | |||
| Name: | Keith Ebling | |||
| Title: | Executive Vice President and General Counsel | |||
Dated: September 2, 2011
3